BPC-157's ability to balance NO signaling in preclinical models positions it as a dual-action candidate: reducing reflux frequency while simultaneously accelerating tissue repair
Observed effects in human trials Reported adverse events across the IV and oral trials included headache, fatigue, dizziness, nasopharyngitis, diarrhea, flatulence, increased appetite, nausea, and back pain
Glutathione is considered to be the most important assistant of detoxification processes in the liver
Nicotinamide Mononucleotide (NMN): Powering Cellular Energy and Repair Nicotinamide Mononucleotide (NMN) is a direct precursor to NAD+
The brains response to an essential amino acid-deficient diet and the circuitous route to a better meal
Non-protein thiol compounds and antioxidant responses involved in bryophyte heavy-metal tolerance